Search results
Results from the WOW.Com Content Network
BF.7 is a shortened version of the sub-variants full name, which is BA.5.2.1.7. This sub-variant is part of Omicron's BA.5 variant, which had the highest number of reported cases globally, accounting for 76.2% of all cases.
Reports from China indicate BF.7 has the strongest infection ability out of the Omicron subvariants in the country, being quicker to transmit than other variants, having a shorter incubation...
BF.7 (BA.5.2.1.7) is a novel sublineage of Omicron BA.5, whose clinical characteristics are not yet established.
BF.7 exhibited a higher transmission than previously emerged SARS-CoV-2. The vaccine against COVID-19 was found to relieve fever, nausea, and vomiting as well as reduce the abnormal ratio of lymphocytes, eosinophils, neutrophils, and the C-reactive protein level.
While BA.5 remains dominant, other omicron subvariants are spreading. BA.4.6 and BF.7 – an offshoot of BA.5 – were responsible for over 13% and 4% of infections this week, respectively.
Reports from China indicate BF.7 has the strongest infection ability out of the omicron subvariants in the country, being quicker to transmit than other variants, having a shorter incubation...
Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection
Objectives: BF.7 (BA.5.2.1.7) is a novel sublineage of Omicron BA.5, whose clinical characteristics are not yet established. Methods: From 28 September 2022 to 3 October 2022, the first 421 patients with BF.7 were assessed in Hohhot China and the clinical data were extracted and analysed.
The seven variants included in this study are important sublineages of the Omicron variants, including BF.7 and BQ.1 as sublineages of BA.5, BA.2.75 as a sublineage of BA.2, and XBB* is ...
BF.7 is a more dangerous subvariant as it spreads rapidly due to high transmissibility and low incubation period.